Advance may open new pathways for cancer immunotherapy.
New venture launched by MIT will support “tough-tech” companies at work on transformative ideas that take time to commercialize.
Study finds bacterial response to drugs varies in different environments.
Cloud-based platform assists in managing, sharing data facilitates research.
Encapsulating molecular components in artificial membranes offers more flexibility in designing circuits.
Freeze-dried cellular components can be rehydrated to churn out useful proteins.